Cargando…
IDF21-0353 Covid19 toe, a late manifestation of mild SARS-CoV-2 with Diabetes
Autores principales: | Jain, R., Seshiah, V., Bhavatharini, N., Shoghli, R., Davey, S., Mohammadabadi, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Scientific Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164609/ http://dx.doi.org/10.1016/j.diabres.2022.109342 |
Ejemplares similares
-
Use of Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitor Remogliflozin and Possibility of Acute Kidney Injury in Type-2 Diabetes
por: Jain, Rajesh, et al.
Publicado: (2022) -
IDF21-0272 Glycemic Variability in patients with SARS-CoV-2 admitted to the ICU
por: Capellan, N., et al.
Publicado: (2022) -
IDF21-0367 Descriptive study of infection by SARS-COV-2 in adults with Diabetes Mellitus
por: Russo, M.P., et al.
Publicado: (2022) -
IDF21-0273 New-Onset Diabetic Ketoacidosis as a first manifestation of Covid-19 at emergency department
por: Dhokar, R., et al.
Publicado: (2022) -
IDF21-0288 Virtually Sugar Free: Overcoming Challenges of Managing Gestational Diabetes (GDM) during a Pandemic
por: Khurana, R., et al.
Publicado: (2022)